Part 1 - A Clinical Trial in Patients With Frequently Relapsing and Steroid-Dependent Nephrotic Syndrome

Withdrawn before enrolling · Phase 2

Conditions studied: Nephrotic Syndrome

In brief

A Clinical Trial Investigating the Safety and Efficacy of ADX-629 in Subjects with Frequently Relapsing and Steroid-Dependent Nephrotic Syndrome

Key facts

Study ID
NCT05599815
Run by
Aldeyra Therapeutics, Inc.
People needed
0
Starts
2023-01-01
Expected to finish
2023-05-01
Last updated by the study team
2024-04-17

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.